Antitumor activity against PDX-derived mouse models observed at minimum effective dose of 0.2 mg/kg. »
05/21/26

OXPHOS significantly lower in prostate cancer cohort. »
05/21/26

Adherence to WCRF/AICR recommendations not consistently associated with MD. »
05/21/26

CorePAM provided incremental value beyond CORE-A. »
05/21/26

MAP-kinase signalling significantly increased in human NSCLC expressing low levels of eIF4A2. »
05/21/26

IOUS-guided localisation has been associated with low positive margin rate. »
05/21/26

Results demonstrate state-of-the-art performance with cross-validated metrics. »
05/22/26

Adropin, asprosin, and resistin correlated strongly with each other. »
05/22/26

P53 mutations associated with poor prognosis in METABRIC cohort. »
05/22/26

Tumor shrinkage reported in approximately 80% of lesions. »
05/22/26